MIDDLE EAST & NORTH AFRICA

The region supplies products with international brand equity, as well as regionally recognised medicines which are supplied across multiple territories within Middle East and North Africa (“MENA”).

Key Countries

Algeria
Egypt
Morocco
Saudi Arabia
Turkey
United Arab Emirates

MENA growth will be mainly driven by Egypt and Turkey over the next three years.
The MENA region is expected to grow in USD by value at 4.6% p.a. four-year CAGR between 2019 and 2023. The largest markets are expected to be Turkey, Saudi Arabia, Egypt, Algeria, UAE and Morocco.

Source: IQVIA Market Prognosis

STATISTICS

Number of products launched:

8

(2019: 7)

Average staff turnover:

10%

(2019: 19%)

Number of product recalls:

Nil

(2019: Nil)

Number of work-related fatalities:

Nil

(2019: Nil)

Number of permanent employees

82

June 2020

79

June 2019

Revenue	2020 R’million	2019 (CER) R’million	Change %
Regional Brands	841	777	8
Sterile Focus Brands	464	385	21
Anaesthetics Brands	266	255	4
Thrombosis Brands	198	130	52

Total	1 305	1 162	12

Note: Commercial Pharmaceuticals revenue by customer geography.